Literature DB >> 3521278

Evaluation of serum CA125 values in healthy individuals and pregnant women.

Y Haga, K Sakamoto, H Egami, R Yoshimura, M Akagi.   

Abstract

CA125 is an antigenic determinant associated with human epithelial ovarian carcinoma. This study was undertaken to evaluate the distribution of serum CA125 levels and the effect of smoking on these levels among healthy individuals and clarify the relation of maternal serum CA125 level and pregnancy. Among 552 healthy individuals, the distribution of serum CA125 values was demonstrated to resemble logarithmic normal distribution. Analysis of variance about age and sex revealed apparent elevation of values for women under 49 years of age in comparison with those for women over 50 years of age and men. Values for these two groups were 143 units/ml for the former and 32 units/ml for the latter, with a 99.7% confidence limit. These values exclude 99.3% of the former and 99.7% of the latter. Serum CA125 values were not affected by smoking. The measurement of serum CA125 levels in 71 pregnant women disclosed a significant elevation during the first trimester in comparison with nonpregnant women under 49 years of age. These results indicate that CA125 values must be deliberatively evaluated in young women, especially during first trimester of pregnancy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3521278     DOI: 10.1097/00000441-198607000-00005

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  11 in total

1.  Correlates of the preoperative level of CA125 at presentation of ovarian cancer.

Authors:  Daniel W Cramer; Allison F Vitonis; William R Welch; Kathryn L Terry; Annekathryn Goodman; Bo R Rueda; Ross S Berkowitz
Journal:  Gynecol Oncol       Date:  2010-09-17       Impact factor: 5.482

Review 2.  Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions.

Authors:  Klaudia Żak; Bartłomiej Zaremba; Alicja Rajtak; Jan Kotarski; Frédéric Amant; Marcin Bobiński
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

3.  Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.

Authors:  K Sakamoto; Y Haga; R Yoshimura; H Egami; Y Yokoyama; M Akagi
Journal:  Gut       Date:  1987-03       Impact factor: 23.059

4.  Serum levels of the oncofetal antigens CA-125, CA 19-9 and CA 15-3 in patients with endometriosis.

Authors:  D Panidis; G Vlassis; J Matalliotakis; S Skiadopoulos; A Kalogeropoulos
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

5.  Measurement of HE4 and CA125 and establishment of reference intervals for the ROMA index in the sera of pregnant women.

Authors:  Jie Lu; Zhipeng Zheng; Qi Zhang; Guoli Li; Fengying Li; Zhian Le; Jun Huang; Xinyou Xie; Jun Zhang
Journal:  J Clin Lab Anal       Date:  2017-11-30       Impact factor: 2.352

Review 6.  MUC16 as a novel target for cancer therapy.

Authors:  Abhijit Aithal; Sanchita Rauth; Prakash Kshirsagar; Ashu Shah; Imayavaramban Lakshmanan; Wade M Junker; Maneesh Jain; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Expert Opin Ther Targets       Date:  2018-07-26       Impact factor: 6.902

7.  Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review.

Authors:  Sileny N Han; Anouk Lotgerink; Mina Mhallem Gziri; Kristel Van Calsteren; Myriam Hanssens; Frédéric Amant
Journal:  BMC Med       Date:  2012-08-08       Impact factor: 8.775

8.  The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma.

Authors:  R E Hawkins; K Roberts; E Wiltshaw; J Mundy; V R McCready
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

9.  Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort.

Authors:  Renée T Fortner; Allison F Vitonis; Helena Schock; Anika Hüsing; Theron Johnson; Raina N Fichorova; Titilayo Fashemi; Hidemi S Yamamoto; Anne Tjønneland; Louise Hansen; Kim Overvad; Marie-Christine Boutron-Ruault; Marina Kvaskoff; Gianluca Severi; Heiner Boeing; Antonia Trichopoulou; Vassiliki Benetou; Carlo La Vecchia; Domenico Palli; Sabina Sieri; Rosario Tumino; Giuseppe Matullo; Amalia Mattiello; N Charlotte Onland-Moret; Petra H Peeters; Elisabete Weiderpass; Inger Torhild Gram; Mie Jareid; J Ramón Quirós; Eric J Duell; Maria-Jose Sánchez; María Dolores Chirlaque; Eva Ardanaz; Nerea Larrañaga; Björn Nodin; Jenny Brändstedt; Annika Idahl; Kay-Tee Khaw; Naomi Allen; Marc Gunter; Mattias Johansson; Laure Dossus; Melissa A Merritt; Elio Riboli; Daniel W Cramer; Rudolf Kaaks; Kathryn L Terry
Journal:  J Ovarian Res       Date:  2017-03-20       Impact factor: 4.234

10.  Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer.

Authors:  S M Scholl; C H Bascou; V Mosseri; R Olivares; H Magdelenat; T Dorval; T Palangié; P Validire; P Pouillart; E R Stanley
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.